DENTOALVEOLAR SURGERY
COMPLICATION RATE OF OSTEOCONDUCTIVE MEMBRANES OVER FRESH ALVEOLAR SOCKETS
Irina Pohodenko-Chudakova 1a, Tamara Tserkhava 2b *, Katsiaryna Maksimovich 1c, Yury Zenkevich 2d
1
Department of Oral Surgery, Dental Faculty, Belarusian State Medical University, Minsk, Republic of Belarus
2
Department of Pediatric Dentistry, Dental Faculty, Belarusian State Medical University, Minsk, Republic of Belarus a
MSD, PhD, Professor, Head b
MSD, PhD, Professor, Head c
DMD, Medical Science Doctoral Student, Assistant d
DMD, Assistant
Academic Editor: Gavriel Chaushu, DMD, MSc, Professor, Tel Aviv University, Tel Aviv, Israel
Received: July 16, 2017
Revised: July 29, 2017 Accepted: August 29, 2017 Published: August 30, 2017
Cite this article: Pohodenko-Chudakova I, Tserakhava T, Maksimovich K, Zenkevich Y. Complication rate of osteoconductive membranes over fresh alveolar sockets. Stoma Edu J. 2017; 4( 3): 171-174.
Abstract
DOI: 10.25241 / stomaeduj. 2017.4( 3). art. 2
Introduction: The aim of the study was to assess the clinical efficacy of the osteoconductive bioresorbable membranes“ Collapan” and“ Collost” used for the preservation of the alveolar process and to compare it with the natural bone healing of an alveolar socket. Materials and methods: The 67 patients observed were divided into 3 groups. The first group included 20 individuals who were treated by covering the alveolus with the“ Collapan” membrane. Group 2 included 22 patients in whom the“ Collost” membrane was used. The third group( control) consisted of 25 patients in whom the alveolus was not covered with any membrane over the natural blood clot. The clinical efficacy of the membranes was based on the number of complications in the postoperative period. Also, the level of alveolar bone reduction was measured using residual height and width as parameters. Results: In the postoperative period, 6( 9 %) complications of an infectious-inflammatory nature were detected in group 1, 2( 3 %)- in group 2, 19( 28 %)- in group 3. The use of the“ Collost” yielded the best result in preserving alveolar height and width. Conclusion: The results of this pilot study showed that it is appropriate to use the osteoplastic bioresorbable“ Collost” and“ Collapan” membranes due to the low incidence of complications and the favourable effect on preserving bone volume. Keywords: dentoalveolar surgery, alveolar socket preservation, osteoconductive membranes.
Original Articles
1. Introduction Preservation of bone volume after tooth loss increases quality of life 1 and allows multiple choices of dental rehabilitation after tooth loss. 2 Loss of alveolar bone volume after tooth extraction remains a challenge in oral surgery, 3 both after tooth extraction and after loss of jaw bone due to tumor lesions in the jaw. 4 The width of the alveolar ridge decreases in range from 25 % to 50 % during the first year, which is 5-7 mm, even in case of absence of complications after tooth extraction. It should be emphasized that 2 / 3 of the loss of the alveolar bone volume occurs during the first three months after tooth extraction. In the same period, there is a significant loss of bone volume in the vertical direction, which, as a rule, is 0.9-3.25 mm. 3 Even removal of the third lower molar can lead to jaw bone loss, 5 even in patients aged 15-35 years. 6 Further, surgical manipulation and multiple curettage of alveolitis sicca could contribute to the progression of alveolar bone atrophy. Bone loss at an age between 15-35 years also bears social and economic significance. 7, 8 The aim of the study was to assess the clinical efficacy of the osteoconductive bioresorbable“ Collapan” and“ Collost” membranes used to minimize bone loss in the alveolar sockets in the lower jaw after tooth extraction and to compare it with the bone wound healing“ under the blood clot”. There were 67 patients( men) under observation, aged 15 to 70 who were divided into 3 groups. All the patients signed the informed agreement for participation in the study, which was approved by the commission on bioethics of the Belarusian State Medical University. The first group included 20 individuals in whom the“ Collapan” membrane( Intermedapatit Ltd, Moscow, Russia) was used. Collapan is a biocomposite, consisting of synthetic hydroxyapatite, collagen and antimicrobial agent( lincomycin hydrochloride,
* Corresponding author: Professor Tamara Tserakhava, MsD, PhD, Head of the Pediatric Dentistry Department, Dental Faculty, Belarusian State Medical University, 74-81, Dzerzhinski Ave., BY-220116 Minsk, Republic of Belarus Tel: + 375 17 272-61-96, Fax: + 375 17 272-61-97, e-mail: tsetam @ mail. ru
Stomatology Edu Journal
171